Dis-Chem Pharmacies Overview
- Year Founded
-
1978
- Status
-
Public
- Employees
-
20,562
- Stock Symbol
-
DCP
- Investments
-
8
- Share Price
-
$2.14
- (As of Monday Closing)
Dis-Chem Pharmacies General Information
Description
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceuticals and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries out its business operations principally in South Africa.
Contact Information
Website
www.dischem.co.zaCorporate Office
- 23 Stag Road
- Glen Austin Ext. 3, Halfway House
- Midrand, Gauteng 1682
- South Africa
Corporate Office
- 23 Stag Road
- Glen Austin Ext. 3, Halfway House
- Midrand, Gauteng 1682
- South Africa
Dis-Chem Pharmacies Stock Performance
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$2.14 | $2.13 | $1.17 - $2.25 | $1.84B | 857M | 896K | $0.06 |
Dis-Chem Pharmacies Financials Summary
In Thousands, USD |
TTM 29-Feb-2024 | FY 2024 29-Feb-2024 | FY 2023 28-Feb-2023 | FY 2022 28-Feb-2022 |
---|---|---|---|---|
EV | 1,584,619 | 1,584,619 | 1,477,471 | 2,162,383 |
Revenue | 1,936,697 | 1,936,697 | 1,948,545 | 2,042,958 |
EBITDA | 154,070 | 154,070 | 165,189 | 160,929 |
Net Income | 52,548 | 52,548 | 59,668 | 57,341 |
Total Assets | 906,796 | 906,796 | 840,955 | 912,251 |
Total Debt | 294,819 | 294,819 | 269,598 | 292,147 |
Dis-Chem Pharmacies Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Dis-Chem Pharmacies Executive Team (4)
Name | Title | Board Seat |
---|---|---|
Rui Morais | Chief Executive Officer | |
Julia Pope | Chief Financial Office, Head of Finance & Executive Director | |
Ivan Saltzman | Co-Founder & Board Member | |
Lynette Saltzman | Co-Founder |
Dis-Chem Pharmacies Board Members (5)
Name | Representing | Role | Since |
---|---|---|---|
Self | Board Member | ||
Dis-Chem Pharmacies | Co-Founder & Board Member | ||
Self | Board Member | ||
Dis-Chem Pharmacies | Chief Executive Officer | ||
Self | Board Member |
Dis-Chem Pharmacies Signals
Dis-Chem Pharmacies Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Dis-Chem Pharmacies Investments & Acquisitions (8)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
OneSpark | 02-Jun-2024 | Life and Health Insurance | |||
Berea Pharmacy | 09-Jun-2023 | Internet Retail | |||
Baby Boom | 01-Mar-2022 | Internet Retail | |||
Kaelo Holdings | 01-Nov-2021 | Insurance Brokers | |||
Medicare Health | 01-Oct-2021 | Merger/Acquisition | Pharmaceuticals |
Dis-Chem Pharmacies Subsidiaries (5)
Company Name | Industry | Location | Founded |
---|---|---|---|
OneSpark | Life and Health Insurance | Johannesburg, South Africa | 2019 |
HealthForce | Acquirer | Rosebank, South Africa | |
Baby Boom | Internet Retail | Kempton Park, South Africa | |
Baby City | Specialty Retail | Durban, South Africa | |
Berea Pharmacy | Internet Retail | Baysville, South Africa |
Dis-Chem Pharmacies ESG
Risk Overview
Risk Rating
Updated March, 28, 2024
23.71 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 16,009
Rank
Percentile
Food Retailers
Industry
of 198
Rank
Percentile
Drug Retail
Subindustry
of 32
Rank
Percentile
Dis-Chem Pharmacies FAQs
-
When was Dis-Chem Pharmacies founded?
Dis-Chem Pharmacies was founded in 1978.
-
Who is the founder of Dis-Chem Pharmacies?
Ivan Saltzman and Lynette Saltzman are the founders of Dis-Chem Pharmacies.
-
Who is the CEO of Dis-Chem Pharmacies?
Rui Morais is the CEO of Dis-Chem Pharmacies.
-
Where is Dis-Chem Pharmacies headquartered?
Dis-Chem Pharmacies is headquartered in Midrand, South Africa.
-
What is the size of Dis-Chem Pharmacies?
Dis-Chem Pharmacies has 20,562 total employees.
-
What industry is Dis-Chem Pharmacies in?
Dis-Chem Pharmacies’s primary industry is Specialty Retail.
-
Is Dis-Chem Pharmacies a private or public company?
Dis-Chem Pharmacies is a Public company.
-
What is Dis-Chem Pharmacies’s stock symbol?
The ticker symbol for Dis-Chem Pharmacies is DCP.
-
What is the current stock price of Dis-Chem Pharmacies?
As of 14-Oct-2024 the stock price of Dis-Chem Pharmacies is $2.14.
-
What is the current market cap of Dis-Chem Pharmacies?
The current market capitalization of Dis-Chem Pharmacies is $1.84B.
-
What is Dis-Chem Pharmacies’s current revenue?
The trailing twelve month revenue for Dis-Chem Pharmacies is $1.94B.
-
What is Dis-Chem Pharmacies’s annual earnings per share (EPS)?
Dis-Chem Pharmacies’s EPS for 12 months was $0.06.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »